The National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program is soliciting applications for early stage translational research projects with the goal of developing basic scientific discoveries into viable therapeutics, devices, and diagnostics to treat heart, lung, blood, and sleep diseases and disorders.
Funding is available for early stage technology development, including:
Therapeutics (Small molecules/Biologics)
– Identifying and characterizing lead compounds
Devices/Diagnostics/Tools
– Developing, testing, and modifying prototypes
– Identifying and developing assay targets
– Developing research tools
Enabling Technologies and Transformative Platforms
– Developing highly-innovative, next-generation technologies that could transform current approaches to clinical practice or translational research (technology must be beyond proof-of-concept and should be ready to begin validation)
– Accelerating the areas of early detection and screening, animal model development, or clinical diagnosis
Learn more about the program and the informational webinar taking place on October 3, 2019 on the NHLBI website.